Trials / Conditions / Undifferentiated Carcinoma
Undifferentiated Carcinoma
3 registered clinical trials studyying Undifferentiated Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Development of Tumor Organoids From Undifferentiated Primary Carcinomas to Guide Therapeutic Decisions NCT06612827 | Centre Francois Baclesse | — |
| Active Not Recruiting | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Pa NCT00565851 | National Cancer Institute (NCI) | Phase 3 |
| Terminated | Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head an NCT00570674 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |